Published in J Biomater Sci Polym Ed on June 21, 2010
Recent advances in bone tissue engineering scaffolds. Trends Biotechnol (2012) 2.13
Biomechanical evaluation of an injectable and biodegradable copolymer P(PF-co-CL) in a cadaveric vertebral body defect model. Tissue Eng Part A (2014) 0.82
Specimen-specific nonlinear finite element modeling to predict vertebrae fracture loads after vertebroplasty. Spine (Phila Pa 1976) (2014) 0.82
Novel biodegradable poly(propylene fumarate)-co-poly(l-lactic acid) porous scaffolds fabricated by phase separation for tissue engineering applications. RSC Adv (2015) 0.80
Tunable tissue scaffolds fabricated by in situ crosslink in phase separation system. RSC Adv (2015) 0.77
Ligament Tissue Engineering Using a Novel Porous Polycaprolactone Fumarate Scaffold and Adipose Tissue-Derived Mesenchymal Stem Cells Grown in Platelet Lysate. Tissue Eng Part A (2015) 0.76
Reformulating polycaprolactone fumarate to eliminate toxic diethylene glycol: effects of polymeric branching and autoclave sterilization on material properties. Acta Biomater (2011) 0.76
A New Vertebral Body Replacement Strategy Using Expandable Polymeric Cages. Tissue Eng Part A (2016) 0.75
Electrically conductive surface modifications of three-dimensional polypropylene fumarate scaffolds. J Biol Regul Homeost Agents (2011) 0.75
Noninvasive Failure Load Prediction of Vertebrae with Simulated Lytic Defects and Biomaterial Augmentation. Tissue Eng Part C Methods (2016) 0.75
Stem cells, growth factors and scaffolds in craniofacial regenerative medicine. Genes Dis (2015) 0.75
Polydopamine-Laced Biomimetic Material Stimulation of Bone Marrow Derived Mesenchymal Stem Cells to Promote Osteogenic Effects. Sci Rep (2017) 0.75
Initial outcome and efficacy of "kyphoplasty" in the treatment of painful osteoporotic vertebral compression fractures. Spine (Phila Pa 1976) (2001) 3.99
Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol (1998) 3.69
Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am (1998) 3.21
Percutaneous vertebroplasty: long-term clinical and radiological outcome. Neuroradiology (2002) 1.78
A novel degradable polycaprolactone networks for tissue engineering. Biomaterials (2003) 1.62
Temperature elevation caused by bone cement polymerization during vertebroplasty. Bone (1999) 1.57
Long-term follow-up of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Clin Rheumatol (2004) 1.35
Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer. Biomaterials (2005) 1.30
In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules (2003) 1.29
Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules (2005) 1.29
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review. J Biomed Mater Res B Appl Biomater (2006) 1.20
Calcium-phosphate and polymethylmethacrylate cement in long-term outcome after kyphoplasty of painful osteoporotic vertebral fractures. Spine (Phila Pa 1976) (2008) 1.17
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
New aspects of the effect of size and size distribution on the setting parameters and mechanical properties of acrylic bone cements. Biomaterials (1996) 1.07
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
Vertebroplasty: an opportunity to do something really good for patients. Spine (Phila Pa 1976) (2000) 1.02
Repeated and multiple new vertebral compression fractures after percutaneous transpedicular vertebroplasty. Spine (Phila Pa 1976) (2009) 0.96
Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant (1999) 0.89
Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement. J Biomed Mater Res (1995) 0.88
Poly(epsilon-caprolactone) as a potential material for a temporary joint spacer. Biomaterials (2002) 0.81
In vitro cytotoxicity of a novel injectable and biodegradable alveolar bone substitute. Biochem Biophys Res Commun (2008) 0.79
In vitro degradation and fracture toughness of multilayered porous poly(propylene fumarate)/beta-tricalcium phosphate scaffolds. J Biomed Mater Res (2002) 0.78
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res (2008) 2.20
Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr (2012) 2.15
Operative management of sacral chordoma. J Bone Joint Surg Am (2005) 2.12
Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am (2008) 1.91
Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials (2009) 1.87
COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation (2008) 1.73
Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials (2005) 1.68
Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67
Surgical treatment of femoroacetabular impingement: evaluation of the effect of the size of the resection. J Bone Joint Surg Am (2005) 1.63
Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials (2008) 1.59
Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc (2009) 1.59
HIV in predominantly rural areas of the United States. J Rural Health (2005) 1.58
Bioactive poly(L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials (2002) 1.47
Effects of simvastatin on osseointegration in a canine total hip arthroplasty model: an experimental study. J Arthroplasty (2011) 1.46
Determination of thigh muscle stiffness using magnetic resonance elastography. J Magn Reson Imaging (2006) 1.46
Applications of magnetic resonance elastography to healthy and pathologic skeletal muscle. J Magn Reson Imaging (2007) 1.39
Designing ideal conduits for peripheral nerve repair. Neurosurg Focus (2009) 1.38
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnology (2007) 1.37
Date of first positive HIV test: reliability of information collected for HIV/AIDS surveillance in the United States. Public Health Rep (2005) 1.35
Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr (2014) 1.33
MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res (2011) 1.32
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Quantitative shear wave magnetic resonance elastography: comparison to a dynamic shear material test. Magn Reson Med (2005) 1.32
Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer. Biomaterials (2005) 1.30
Bone-tissue-engineering material poly(propylene fumarate): correlation between molecular weight, chain dimensions, and physical properties. Biomacromolecules (2006) 1.30
Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules (2005) 1.29
Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol (2003) 1.29
The 2009 Frank Stinchfield Award: "Hip squeaking": a biomechanical study of ceramic-on-ceramic bearing surfaces. Clin Orthop Relat Res (2009) 1.28
A spermatogenesis-related gene expression profile in human spermatozoa and its potential clinical applications. J Mol Med (Berl) (2004) 1.28
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27
Racial and ethnic disparities in HIV diagnoses for women in the United States. J Acquir Immune Defic Syndr (2006) 1.27
Using the HIV surveillance system to monitor the National HIV/AIDS Strategy. Am J Public Health (2012) 1.27
Fabrication and characterization of poly(propylene fumarate) scaffolds with controlled pore structures using 3-dimensional printing and injection molding. Tissue Eng (2006) 1.26
Physical properties and cellular responses to crosslinkable poly(propylene fumarate)/hydroxyapatite nanocomposites. Biomaterials (2008) 1.26
Limb sparing surgery for bone tumours of the shoulder girdle: the oncological and functional results. Int Orthop (2009) 1.25
Quantitative analysis of interconnectivity of porous biodegradable scaffolds with micro-computed tomography. J Biomed Mater Res A (2004) 1.23
Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication. Nat Nanotechnol (2013) 1.23
Thigh muscle stiffness assessed with magnetic resonance elastography in hyperthyroid patients before and after medical treatment. J Magn Reson Imaging (2007) 1.23
A biofilm approach to detect bacteria on removed spinal implants. Spine (Phila Pa 1976) (2010) 1.22
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir Physiol Neurobiol (2009) 1.22
Stimulation of neurite outgrowth using positively charged hydrogels. Biomaterials (2009) 1.21
Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A (2009) 1.21
Metastatic bone disease: diagnosis, evaluation, and treatment. J Bone Joint Surg Am (2009) 1.21
Poly(propylene fumarate) bone tissue engineering scaffold fabrication using stereolithography: effects of resin formulations and laser parameters. Biomacromolecules (2007) 1.20
A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds. Biomaterials (2012) 1.18
Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery (2002) 1.18
Validation of shear wave elastography in skeletal muscle. J Biomech (2013) 1.18
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Surgical treatment of femoroacetabular impingement: evaluation of the effect of the size of the resection. Surgical technique. J Bone Joint Surg Am (2006) 1.16
C1 anatomy and dimensions relative to lateral mass screw placement. Spine (Phila Pa 1976) (2007) 1.16
Photo-cross-linked hybrid polymer networks consisting of poly(propylene fumarate) and poly(caprolactone fumarate): controlled physical properties and regulated bone and nerve cell responses. Biomacromolecules (2008) 1.16
Increased HIV and primary and secondary syphilis diagnoses among young men--United States, 2004-2008. J Acquir Immune Defic Syndr (2011) 1.14
Mechanical effects of partial sacrectomy: when is reconstruction necessary? Clin Orthop Relat Res (2006) 1.13
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
Identification of testis development and spermatogenesis-related genes in human and mouse testes using cDNA arrays. Mol Hum Reprod (2002) 1.12
Severe osteogenesis imperfecta in cyclophilin B-deficient mice. PLoS Genet (2009) 1.12
Reconstruction after total sacrectomy: early experience with a new surgical technique. Clin Orthop Relat Res (2005) 1.11
Metastatic disease of the spine: evaluation and treatment. Clin Orthop Relat Res (2003) 1.11
Identification and characterization of a novel human testis-specific Golgi protein, NYD-SP12. Mol Hum Reprod (2003) 1.08
Relationship between surgical margins and local recurrence in sarcomas of the spine. Clin Orthop Relat Res (2002) 1.07
Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis. J Exp Clin Cancer Res (2013) 1.07
Shear elastic modulus estimation from indentation and SDUV on gelatin phantoms. IEEE Trans Biomed Eng (2011) 1.06
Total en bloc spondylectomy of C5 vertebra for chordoma. Spine (Phila Pa 1976) (2007) 1.05
Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J (2012) 1.05
Bowel and bladder function after major sacral resection. Clin Orthop Relat Res (2002) 1.04
Enhanced cell ingrowth and proliferation through three-dimensional nanocomposite scaffolds with controlled pore structures. Biomacromolecules (2010) 1.04
Photo-crosslinked poly(epsilon-caprolactone fumarate) networks for guided peripheral nerve regeneration: material properties and preliminary biological evaluations. Acta Biomater (2009) 1.04
Methods for in vitro characterization of multichannel nerve tubes. J Biomed Mater Res A (2008) 1.04
Silicon effects on photosynthesis and antioxidant parameters of soybean seedlings under drought and ultraviolet-B radiation. J Plant Physiol (2010) 1.02
Controlling dispersion of axonal regeneration using a multichannel collagen nerve conduit. Biomaterials (2010) 1.02
Nerve tubes for peripheral nerve repair. Neurosurg Clin N Am (2009) 1.02
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol (2004) 1.02
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem (2013) 1.01
Histone deacetylase 3 is required for maintenance of bone mass during aging. Bone (2012) 1.01
Accurate monitoring of the HIV epidemic in the United States: case duplication in the national HIV/AIDS surveillance system. J Acquir Immune Defic Syndr (2008) 1.01
The development of electrically conductive polycaprolactone fumarate-polypyrrole composite materials for nerve regeneration. Biomaterials (2010) 1.01